1-4 of 4
Adam Rosenthal
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Siltuximab is associated with improved progression-free survival in idiopathic multicentric Castleman disease

Frits van Rhee, Adam Rosenthal, Karan Kanhai, Rabecka Martin, Katherine Nishimura, Antje Hoering, David C. Fajgenbaum
Journal: Blood Advances
Blood Adv (2022) 6 (16): 4773–4781.
https://doi.org/10.1182/bloodadvances.2022007112
Published: 2022
Includes: Supplemental data
Journal Articles

Long-term outcomes after autologous stem cell transplantation for multiple myeloma

Clinical Trials & Observations
Katherine K. Nishimura, Bart Barlogie, Frits van Rhee, Maurizio Zangari, Brian A. Walker, Adam Rosenthal, Carolina Schinke, Sharmilan Thanendrarajan, Faith E. Davies, Antje Hoering, Gareth J. Morgan
Journal: Blood Advances
Blood Adv (2020) 4 (2): 422–431.
https://doi.org/10.1182/bloodadvances.2019000524
Published: 2020
Includes: Supplemental data
Journal Articles

Occurrence, thromboembolic risk, and mortality in Danish patients with cold agglutinin disease

Clinical Trials & Observations
Lauren C. Bylsma, Anne Gulbech Ording, Adam Rosenthal, Buket Öztürk, Jon P. Fryzek, Jaime Morales Arias, Alexander Röth, Sigbjørn Berentsen
Journal: Blood Advances
Blood Adv (2019) 3 (20): 2980–2985.
https://doi.org/10.1182/bloodadvances.2019000476
Published: 2019
Includes: Supplemental data
Journal Articles

Cold agglutinin disease burden: a longitudinal analysis of anemia, medications, transfusions, and health care utilization

Clinical Trials & Observations
Megan Mullins, Xiaohui Jiang, Lauren C. Bylsma, Jon P. Fryzek, Heidi Reichert, Evan C. Chen, Shivaani Kummar, Adam Rosenthal
Journal: Blood Advances
Blood Adv (2017) 1 (13): 839–848.
https://doi.org/10.1182/bloodadvances.2017004390
Published: 2017
Includes: Supplemental data